soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 Semaglutide and Cardiovascular Outcomes in

That means that 1 in 100 people using oral contraceptives will get pregnant each year even if they take their pill religiously at the same time every day

The decision about which weight loss option is appropriate should always be made in partnership with your doctor, who will consider several important factors, including: Your overall health Medical history Current medications The amount of weight youre aiming to lose Your tolerance for certain treatments Always talk with your doctor when exploring effective weight loss options

Under Bra - 195 - 225 Say farewell to bra bulges with this treatment

March 13, 2026: FDA Sends Warning Letter to Novo Nordisk The FDA has sent a warning letter to the maker of Ozempic and Wegovy over a potential failure to report side effects connected to these drugs